SEC Stock Data Quick Answer ACME UNITED CORP reported Stockholders Equity of $117.61 million for fiscal year 2025. ACME UNITED CORP Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $117.61M +9.9% 2024 $106.98M +9.3% 2023 $97.90M +23.9% 2022 $79.03M +2.5% 2021 $77.08M +22.9% 2020 $62.72M +12.6% 2019 $55.70M +6.4% 2018 $52.33M +4.8% 2017 $49.94M … Read more
Quick Answer ACME UNITED CORP reported Long-Term Debt of $11.85 million for fiscal year 2025. ACME UNITED CORP Long-Term Debt — Annual History Fiscal Year Long-Term Debt YoY Change 2025 $11.85M -32.7% 2024 $17.61M +34.3% 2023 $13.10M -73.7% 2022 $49.92M +51.1% 2021 $33.04M -14.8% 2020 $38.77M +16.6% 2019 $33.24M -17.5% 2018 $40.28M -7.3% 2017 $43.45M … Read more
Quick Answer ACME UNITED CORP reported Cash and Equivalents of $3.60 million for fiscal year 2025. ACME UNITED CORP Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $3.60M -43.8% 2024 $6.40M +33.4% 2023 $4.80M -21.4% 2022 $6.10M +26.0% 2021 $4.84M +16.2% 2020 $4.17M -38.9% 2019 $6.82M +54.7% 2018 $4.41M … Read more
Quick Answer ACME UNITED CORP reported Total Assets of $171.00 million for fiscal year 2025. ACME UNITED CORP Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $171.00M +5.4% 2024 $162.17M +8.7% 2023 $149.24M -9.2% 2022 $164.38M +13.8% 2021 $144.44M +11.2% 2020 $129.87M +17.3% 2019 $110.75M +1.2% 2018 $109.48M -4.6% 2017 $114.73M … Read more
Quick Answer ACME UNITED CORP reported Diluted EPS of $2.49 per share for fiscal year 2025. ACME UNITED CORP Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 $2.49 +1.6% 2024 $2.45 -49.6% 2023 $4.86 +492.7% 2022 $0.82 -76.2% 2021 $3.45 +49.4% 2020 $2.31 +44.4% 2019 $1.60 +23.1% 2018 $1.30 +19.3% 2017 … Read more
Quick Answer ACME UNITED CORP reported Net Income of $10.18 million for fiscal year 2025. ACME UNITED CORP Net Income — Annual History Fiscal Year Net Income YoY Change 2025 $10.18M +1.6% 2024 $10.02M -43.7% 2023 $17.79M +486.3% 2022 $3.03M -77.8% 2021 $13.66M +68.6% 2020 $8.10M +46.9% 2019 $5.51M +19.9% 2018 $4.60M +13.5% 2017 $4.05M … Read more
Quick Answer ACME UNITED CORP reported Total Revenue of $196.54 million for fiscal year 2025. ACME UNITED CORP Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $196.54M +1.1% 2024 $194.49M +1.6% 2023 $191.50M -1.3% 2022 $193.96M +6.5% 2021 $182.09M +11.0% 2020 $164.00M +15.1% 2019 $142.46M +3.7% 2018 $137.32M +5.2% 2017 $130.55M … Read more
Quick Answer ACME UNITED CORP reported Total Revenue of $196.54 million for fiscal year 2025. ACME UNITED CORP — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $196.54M+1.1% $194.49M+1.6% $191.50M-1.3% $193.96M+6.5% $182.09M+11.0% $164.00M+15.1% Net Income $10.18M+1.6% $10.02M-43.7% $17.79M+486.3% $3.03M-77.8% $13.66M+68.6% $8.10M+46.9% Diluted EPS $2.49+1.6% $2.45-49.6% $4.86+492.7% $0.82-76.2% $3.45+49.4% $2.31+44.4% Total … Read more
Quick Answer ACTUATE THERAPEUTICS, INC. reported Shares Outstanding of 23.25 million shares for fiscal year 2025. ACTUATE THERAPEUTICS, INC. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 23.25M +19.0% 2024 19.53M +1055.2% 2023 1.69M — Quarterly Shares Outstanding Quarter Ending Shares Outstanding YoY QoQ September 30, 2025 23.24M +19.0% +13.5% June … Read more
Quick Answer ACTUATE THERAPEUTICS, INC. reported Operating Income of -$22.50 million for fiscal year 2025. ACTUATE THERAPEUTICS, INC. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$22.50M +10.6% 2024 -$25.16M -0.7% 2023 -$24.97M — Quarterly Operating Income Quarter Ending Operating Income YoY QoQ September 30, 2025 -$5.47M -1.5% +8.3% June 30, … Read more